Xylometazoline and Cocaine for Nasal Vasoconstriction
NCT05334017
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Epistaxis
Interventions
DRUG:
Xylometazoline 0,1%
DRUG:
Cocaine 4%
Sponsor
Rigshospitalet, Denmark